Warning! GuruFocus detected
3 Severe warning signs
with 8ZN.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
JD Health International Inc
ISIN : KYG5074A1004
Compare
Compare
Traded in other countries / regions
06618.Hong Kong8ZN.GermanyJDHIF.USA IPO Date
2020-12-17Description
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2023, the platform has over 180 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 186.51 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.05 | |||||
| Interest Coverage | 180.77 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 5.2 | |||||
| Beneish M-Score | 1.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17.4 | |||||
| 3-Year FCF Growth Rate | 8.3 | |||||
| 3-Year Book Growth Rate | 6.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 9.65 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 12.28 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 8.79 | |||||
| 9-Day RSI | 19.63 | |||||
| 14-Day RSI | 28.78 | |||||
| 3-1 Month Momentum % | 23.21 | |||||
| 6-1 Month Momentum % | 2.99 | |||||
| 12-1 Month Momentum % | 42.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.77 | |||||
| Quick Ratio | 3.39 | |||||
| Cash Ratio | 3.11 | |||||
| Days Inventory | 45.33 | |||||
| Days Sales Outstanding | 2.59 | |||||
| Days Payable | 84.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.02 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 22.89 | |||||
| Operating Margin % | 2.55 | |||||
| Net Margin % | 7.16 | |||||
| FCF Margin % | 7.42 | |||||
| ROE % | 7.92 | |||||
| ROA % | 6.12 | |||||
| ROIC % | 7.34 | |||||
| 3-Year ROIIC % | 24.25 | |||||
| ROC (Joel Greenblatt) % | 787.87 | |||||
| ROCE % | 9.07 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.81 | |||||
| Forward PE Ratio | 20 | |||||
| PE Ratio without NRI | 19.49 | |||||
| Price-to-Owner-Earnings | 28.06 | |||||
| PS Ratio | 1.49 | |||||
| PB Ratio | 1.6 | |||||
| Price-to-Tangible-Book | 1.66 | |||||
| Price-to-Free-Cash-Flow | 20.11 | |||||
| Price-to-Operating-Cash-Flow | 20.04 | |||||
| EV-to-EBIT | 7.37 | |||||
| EV-to-Forward-EBIT | 12.48 | |||||
| EV-to-EBITDA | 7.37 | |||||
| EV-to-Forward-EBITDA | 11.5 | |||||
| EV-to-Revenue | 0.61 | |||||
| EV-to-Forward-Revenue | 0.54 | |||||
| EV-to-FCF | 11.72 | |||||
| Price-to-GF-Value | 0.51 | |||||
| Price-to-Projected-FCF | 0.99 | |||||
| Price-to-Graham-Number | 1.2 | |||||
| Price-to-Net-Current-Asset-Value | 2.08 | |||||
| Price-to-Net-Cash | 2.74 | |||||
| Earnings Yield (Greenblatt) % | 13.57 | |||||
| FCF Yield % | 5.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JD Health International Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 7,540.5 | ||
| EPS (TTM) (€) | 0.171 | ||
| Beta | 1.28 | ||
| 3-Year Sharpe Ratio | 0.05 | ||
| 3-Year Sortino Ratio | 0.1 | ||
| Volatility % | 63.7 | ||
| 14-Day RSI | 28.78 | ||
| 14-Day ATR (€) | 0.132927 | ||
| 20-Day SMA (€) | 3.928 | ||
| 12-1 Month Momentum % | 42.76 | ||
| 52-Week Range (€) | 2.26 - 4.8 | ||
| Shares Outstanding (Mil) | 3,199.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JD Health International Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JD Health International Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
JD Health International Inc Frequently Asked Questions
What is JD Health International Inc(STU:8ZN)'s stock price today?
The current price of STU:8ZN is €3.32. The 52 week high of STU:8ZN is €4.80 and 52 week low is €2.26.
When is next earnings date of JD Health International Inc(STU:8ZN)?
The next earnings date of JD Health International Inc(STU:8ZN) is 2025-08-15 Est..
Does JD Health International Inc(STU:8ZN) pay dividends? If so, how much?
JD Health International Inc(STU:8ZN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers